A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in endemic countries

Journal of Pediatrics

Volumn 130, Issue 6, 1997, Pages 981-986

  Lee, C Y ^a   Lee, P I ^a   Huang, L M ^a   Chen, J M ^a   Chang, M H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; ORAL POLIOMYELITIS VACCINE; TETANUS ANTIBODY;

ANOREXIA; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENDEMIC DISEASE; ERYTHEMA; FEVER; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; VOMITING;

EID: 0030658869     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70287-7     Document Type: Article

References (30)

1. RP Beasley LY Hwang CC Lin ML Leu CE Stevens W Szmuness Incidence of hepatitis B virus infections in preschool children in Taiwan J Infect Dis 146 1982 198 204
2. CE Stevens RP Beasley JJ Tsui WC. Lee Vertical transmission of hepatitis B antigen in Taiwan N Engl J Med 292 1975 771 774
3. DS Chen NH Hsu JL Sung TC Hsu ST Hsu YT Kuo A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers JAMA 257 1987 2597 2603
4. HL Chen MH Chang YH Ni HY Hsu PI Lee CY Lee Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan JAMA 276 1996 906 908
5. G Da Villa RI Piazza R Iorio L Picciotto P Peluso A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas J Med Virol 36 1992 274 278
6. GE King SC. Hadler Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious Pediatr Infect Dis J 13 1994 394 407
7. RP Beasley LY Huang CY Lee CC Lan CH Roan FY Huang Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin (HBIG) in combination with HB vaccine Lancet 2 1983 1099 1102
8. PM Grosheide R del Canho RA Heijtink ASM Nuijten J Zwijnenberg JRJ Bänffer Passive-active immunization in infants of hepatitis B e antigen-positive mothers: comparison of the efficacy of early and delayed active immunization Arch Pediatr Adoles Med [Am J Dis Child] 147 1993 1316 1320
9. DP. Greenberg Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies Pediatr Infect Dis J 12 1993 438 445
10. Y Sato H Sato Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system Infect Immun 46 1984 415 421
11. H Sato Y Sato A Ito Affinity of pertussis toxin produced by Bordetella pertussis for human haptoglobin: application to the in vitro assay of the toxin J Microbiol Methods 1 1983 99 109
12. JJ Miller Jr RJ Silverberg TM Saito JB Humber An agglutinative reaction for Hemophilus pertussis J Pediatr 22 1943 644 651
13. S Millian CE Cherubin R Sherwin HT. Fuerst A serologic survey of tetanus and diphtheria in immunity in New York City Arch Environ Health 15 1967 776 781
14. M Quevillon A. Chagnon Microtissue culture test for the titration of low concentrations of diphtheria antitoxin in minimal amounts of human sera Appl Environ Microbiol 25 1973 1 4
15. JWG. Smith Diphtheria and tetanus toxoids Br Med Bull 25 1969 177 182
16. JP Chiron P Coursaget B Yvonnet F Auger QT Lee F Barin Simultaneous administration of hepatitis B and diphtheria/tetanus/pertussis/polio vaccines Lancet 1 1984 623 624
17. LM Huang CY Lee CY Hsu SS Huang CL Kao FF Wu Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine Pediatr Infect Dis J 9 1990 461 465
18. HM Inskip AJ Hall J Chotard F Loik H. Whittle Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response Int J Epidemiol 20 1991 764 769
19. R Booy SJM Aitken S Taylor G Tudor-Williams JA Macfarlane ER Moxon Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age Lancet 339 1992 507 510
20. LJ Baraff RD Leake DG Burstyn T Payne CL Cody CR Manclark Immunologic response of early and routine DTP immunisation in infants Pediatrics 73 1984 37 42
21. The World Health Organization's Expanded Programme on Immunization: a global overview World Health Stat Q 38 1985 232 252
22. JL. Melnick International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine Ann N Y Acad Sci 754 1995 267 272
23. CY Lee LM Huang MH Chang CY Hsu SJ Wu JL Sung The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers Pediatr Infect Dis J 10 1991 299 303
24. PI Lee CY Lee LM Huang MH. Chang Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to hepatitis B e antigen-positive mothers J Pediatr 126 1995 716 721
25. LM Huang CY Lee TY Lin JM Chen PI Lee CY. Hsu Response to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age Vaccine 14 1996 916 922
26. JA Englund MD Decker KM Edwards ME Pichichero MC Steinhoff EL. Anderson Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study Pediatrics 93 1994 37 43
27. S Feldman S Perry M Andrew L Jones JE. Moffitt Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children J Pediatr 121 1992 857 861
28. DI Bernstein VE Smith GM Schiff HM Rathfon JA. Boscia Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age Pediatr Infect Dis J 12 1993 131 135
29. ME Pichichero AB Francis MM Blatter KS Reisinger JL Green SM Marsocci Acellular pertussis vaccination of 2-month-old infants in the United States Pediatrics 89 1992 882 887
30. KM Edwards Acellular pertussis vaccines—a solution to the pertussis problem? J Infect Dis 168 1993 15 20